Cutera Receives ANVISA Approval of truSculpt® Body Sculpting Systems in Brazil
July 23 2019 - 8:00PM
Business Wire
CUTERA, INC., (Nasdaq: CUTR) ("Cutera" or the "Company") a
leading provider of laser, light and other energy-based aesthetic
systems for practitioners worldwide, announced today that Brazil's
healthcare regulatory authority, Agência Nacional de Vigilância
Sanitária ("ANVISA"), recently granted regulatory approval for
truSculpt® iD and truSculpt 3D systems. The truSculpt family of
devices use innovative monopolar radiofrequency technology to
elevate tissue temperature for fat reduction and are approved by
ANVISA for body sculpting and contouring, circumferential
reduction, the treatment of skin laxity, and for the improvement in
the appearance of cellulite.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190723005824/en/
(Graphic: Business Wire)
"Brazil is a large and fast-growing aesthetic market, and we are
pleased to add this to our product offerings in Brazil and selected
markets throughout South America," said Cutera's Chief Executive
Officer, David Mowry. "truSculpt is enormously popular for patients
seeking body contouring treatments in the United States. This
ANVISA clearance allows us to further partner with our South
American physician customers to enhance their practices," added
Jason Richey, Cutera's President.
Sao Paulo-based Endocrinologist, Dr. Elaine Dias Jakubowski, is
the first provider to introduce the truSculpt technology into her
practice in Brazil. "We've been monitoring the progress of body
sculpting technologies from Cutera in the US for some time now and
have researched the options for the best body shaping device. We
are pleased with truSculpt's clinical results, its ability to treat
all different patient body types, as well as its best-in-class
design and functionality. With radiofrequency (RF) technology, we
are excited to begin offering this service to patients looking to
reduce body fat in stubborn areas, where diet and exercise alone
don't achieve the desired results. We look forward to growing our
practice in Sao Paulo through truSculpt."
Research shows the Latin American market for energy-based
devices (EBD), including body shaping and aesthetics, was $211M in
2018, with a projected 5-year compound annual growth rate (CAGR) of
10%.1
Commercial shipments of truSculpt systems to Brazil are expected
to begin immediately.
The Company launched truSculpt iD in the US in 2018, and
truSculpt 3D in 2017.
About truSculpt Systems
truSculpt is a non-surgical fat reduction treatment that uses
monopolar radiofrequency (RF) technology. truSculpt offers two
options for non-surgical monopolar radiofrequency body sculpting.
Both systems are clinically proven to get rid of stubborn fat cells
permanently by an average of 24%2, even in areas that are resistant
to diet and exercise.
truSculpt iD
Personalized body sculpting for any shape or body type. The
revolutionary truSculpt iD is clinically proven to eliminate fat in
as little as one 15-minute hands-free treatment, completely
personalized to an individual's needs.
truSculpt 3D
A new dimension in body sculpting with a multi-dimensional
approach. truSculpt 3D gives individuals the power to reshape
dimension, improve definition, and reduce overall depth in one
simple 60-minute provider hand-held treatment.
Additional information can be found: trusculpt.com
cutera.com/trusculptiD cutera.com/trusculpt3D
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser
and other energy-based aesthetic systems for practitioners
worldwide. Since 1998, Cutera has been developing innovative,
easy-to-use products that enable physicians and other qualified
practitioners to offer safe and effective aesthetic treatments to
their patients. For more information, call +1 415-657-5500 or
1-888-4CUTERA or visit cutera.com.
Sources:
- Medical Insight, Inc.
- Amy Taub, MD, Study ASDS 2017 Poster
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190723005824/en/
Tanya Rodante Director of Marketing Communications +1
415-657-5500 trodante@cutera.com
Cutera (NASDAQ:CUTR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cutera (NASDAQ:CUTR)
Historical Stock Chart
From Apr 2023 to Apr 2024